Lonza Group (OTCMKTS:LZAGY) Sees Unusually-High Trading Volume – Time to Buy?

Shares of Lonza Group Ag (OTCMKTS:LZAGY) saw unusually-strong trading volume on Wednesday . Approximately 132,358 shares traded hands during mid-day trading, an increase of 96% from the previous session’s volume of 67,653 shares.The stock last traded at $65.6850 and had previously closed at $67.15.

Analyst Upgrades and Downgrades

Separately, Zacks Research downgraded Lonza Group from a “hold” rating to a “strong sell” rating in a research note on Wednesday, February 4th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Lonza Group Price Performance

The company’s 50-day moving average is $68.13 and its two-hundred day moving average is $68.55. The company has a current ratio of 1.46, a quick ratio of 0.87 and a debt-to-equity ratio of 0.48.

About Lonza Group

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.